2014 ASSA International IWPCPS-16 Workshops: Spatially-Resolved Raman Imaging for Ingredient-Specific Characterization of Combination Dry Powder Inhalers
June 17, 2014 Since the approval of Dry Powder Inhalers containing Fluticasone Propionate and Salmeterol Xinafoate in 1999, combination inhaled therapies have dominated the COPD market. However, due to the lack of specific guidance of the Office of Generic Drugs as to the abbreviated new drug application submission, there was…
Shedding Light on the Utility of FTIR vs. Raman Spectroscopy
Read Gateway Analytical's piece on shedding light on the utility of FTIR vs. Raman spectroscopy.
What is Pharmaceutical Forensics?
Watch Gateway Analytical's Dave Exline discuss our pharmaceutical forensics services.
Comparison of Raman and FTIR Spectroscopy: Advantages and Limitations
Authors & Contributors David Exline October 09, 2013
2018 RDD Conference: Analysis of a Dry Powder Inhaler Active Pharmaceutical Ingredient Using Scanning Electron Microscopy
Download our presentation from 2018 RDD Conference on Analysis of a Dry Powder Inhaler Active Pharmaceutical Ingredient Using Scanning Electron Microscopy.
Wear Debris Characterization using Automated Raman and SEM-EDS
Authors & ContributorsRebekah ByrneDavid ExlineSeptember 17, 2015
Gateway Analytical Presents on Analytical Testing Methods for Inhalable Drug Products at Medicon Valley Inhalation Symposium
Gateway Analytical announces participation in the...
Chemically Specific API Particle Sizing Using Automated Raman Spectroscopy
The active pharmaceutical ingredient (API)...
Gateway Analytical to Present Latest Methodologies for Glass Delamination Analysis at Annual Meeting of Pharmaceutical Scientists
Gateway Analytical announced today that they...